What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly announce IDEXX Laboratories' financial results for the second quarter ended June 30, 2006.

Where can I find the specific financial details of the second quarter results?

The specific financial details are contained within the press release titled 'IDEXX Laboratories Announces Second Quarter Results,' which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for detailed performance metrics.

What does it mean that the information is furnished 'under Item 2.02' and 'shall not be deemed filed'?

This means that while the information is being disclosed to the public, it is not subject to the same liability provisions under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed'. This is a standard disclaimer for earnings releases furnished with an 8-K.

Who signed this report on behalf of IDEXX Laboratories?

The report was signed by Merilee Raines, who holds the positions of Vice President, Chief Financial Officer, and Treasurer for IDEXX Laboratories.

IDXX 8-K: Earnings & Results

Summary

This 8-K filing from IDEXX LABORATORIES INC /DE (IDXX) primarily serves to announce the company's financial results for the second quarter ended June 30, 2006. The report itself does not contain detailed financial figures but rather refers investors to an accompanying press release (Exhibit 99.1) for the specific results. This practice is common for 8-K filings related to earnings announcements. Investors should consult the furnished press release for a comprehensive understanding of IDEXX's performance, including key metrics like revenue, earnings per share, and any forward-looking guidance or commentary provided by management. The filing signifies that the company has met its reporting obligation by disclosing these important operational and financial updates to the public.

Key Highlights

1IDEXX Laboratories announced its financial results for the second quarter ended June 30, 2006.
2The company filed a Form 8-K to report these results.
3The detailed financial results are provided in a press release (Exhibit 99.1) attached to the 8-K.
4The filing is made under Item 2.02 (Results of Operations and Financial Condition).
5The information furnished under Item 2.02 is not considered 'filed' for purposes of Section 18 of the Exchange Act.
6The filing includes a signature by Merilee Raines, Vice President, Chief Financial Officer, and Treasurer.

IDEXX LABORATORIES INC /DE 8-K Report, Financial Results (Jul 28, 2006)

Summary

Key Highlights

Frequently Asked Questions